HMG-CoA reductase inhibition may reduce intratumoural autocrine hormone production by lowering intracellular cholesterol, promote apoptosis breast cancer cells through inducing nitric oxide synthase expression [37, 38]. This evidence concerns the gene HMGCR and breast carcinoma.